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Abstract
Background: The spread of Aedes albopictus, a vector for re-emergent arbovirus diseases like chikungunya and dengue,
points up the need for better control strategies and new tools to evaluate transmission risk. Human antibody (Ab) responses
to mosquito salivary proteins could represent a reliable biomarker for evaluating human-vector contact and the efficacy of
control programs.
Methodology/Principal Findings: We used ELISA tests to evaluate specific immunoglobulin G (IgG) responses to salivary
gland extracts (SGE) in adults exposed to Aedes albopictus in Reunion Island. The percentage of immune responders (88%)
and levels of anti-SGE IgG Abs were high in exposed individuals. At an individual level, our results indicate heterogeneity of
the exposure to Aedes albopictus bites. In addition, low-level immune cross-reactivity between Aedes albopictus and Aedes
aegypti SGEs was observed, mainly in the highest responders.
Conclusion/Significance: Ab responses to saliva could be used as an immuno-epidemiological tool for evaluating exposure
to Aedes albopictus bites. Combined with entomological and epidemiological methods, a ‘‘salivary’’ biomarker of exposure
to Aedes albopictus could enhance surveillance of its spread and the risk of arbovirus transmission, and could be used as a
direct tool for the evaluation of Aedes albopictus control strategies.
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Introduction
The incidence of arthropod-borne disease is on the rise and
mosquito-borne diseases in particular constitute a world-wide
threat [1]. In Asia, Africa and South America, arbovirus diseases
are re-emerging, notably dengue and chikungunya. According to
the World Health Organization, there are 50 million cases of
dengue fever every year and the number of countries declaring
cases is increasing [2] Chikungunya is an emerging arbovirus [3]
and several outbreaks have been recorded, such as the 2006
epidemic on Reunion Island in the Indian Ocean [4]. The threat
of these diseases in the developed world is real with, in addition to
the chikungunya outbreak in Italy in 2007 [5], sporadic
autochthonous cases of dengue and chikungunya recently reported
in Southern France [6]. Therefore, epidemiological tools for
evaluating such risks are urgently needed in both developing and
developed countries. Aedes aegypti and Aedes albopictus are both
vectors of the dengue and chikungunya viruses, and Ae. albopictus
populations are dramatically expanding worldwide. Epidemiolog-
ical evaluation of Aedes-borne diseases is currently based on
pathogen detection in human populations and entomological
methods. The exposure of human populations to Aedes is currently
evaluated by mapping breeding sites and using mosquito-capture
strategies. But these methods have substantial limitations when it
comes to large-scale studies in the field, e.g. vector density and
transmission risk are estimated by counting immature Aedes in
breeding sites to derive House and Breteau Indices, a process
which is too demanding for regular implementation in the field
[7], especially in the urban setting. In addition, current methods
for evaluating Aedes exposure are mainly applicable at the
population level and cannot be used to gauge the heterogeneity
of individual exposure. In order to improve vector control and
follow the risk of arbovirus transmission, much effort is being
devoted to developing new, simple, rapid and sensitive indicators
to evaluate human exposure to Aedes bites and thus the risk of
arbovirus transmission in exposed populations. One promising
www.plosntds.org 1 February 2012 | Volume 6 | Issue 2 | e1487approach is based on the idea that exposure could be directly
assessed by measuring human-vector contact as reflected by the
human antibody (Ab) response to arthropod salivary proteins [8].
At the time of biting, the female mosquito injects saliva containing
biologically active molecules to favour feeding and some of these
are highly immunogenic [9]. Human Ab responses to the saliva of
a number of vectors, including Triatoma (Chagas disease) [10] and
Phlebotomus (Leishmaniasis) [11], have been identified as promising
biomarkers for vector exposure. Ab responses to the saliva of
Glossina (the vector of Human African Trypanosomiasis) have been
shown to have high diagnostic value [12]. For mosquitoes, Ab
responses to whole saliva have been correlated to human exposure
to Culex mosquitoes [13], and Anopheles gambiae [14], Anopheles dirus
[15] and Anopheles darlingi [16], vectors of Plasmodium. Recently, it
has been shown that the IgG response to whole An. gambiae saliva
could be a useful biomarker for evaluating the efficacy of malaria
vector control [17]. Studies on Ab responses to Aedes saliva have
tended to focus on human allergic reactions [18] and the
identification of the immunogenic proteins [19] although they
have shown that quantitative evaluation of anti-saliva Ab
responses (IgG and specific isotypes) could give a measure of
human exposure to biting Aedes [20], [21]. It was recently
demonstrated that IgM and IgG responses to Ae. aegypti saliva
could be used to estimate exposure in transiently exposed
populations [22]. Finally, recent data showed that IgE and IgG4
responses to Ae. aegypti saliva could be detected in young
Senegalese children during the exposure season [23]. The present
study addresses one important application of this salivary
biomarker as a tool to evaluate the specific exposure of individuals
to Ae. albopictus bites. Human IgG responses to Ae. albopictus
saliva (salivary gland extracts; SGE) were measured in adults
living on Reunion Island. In this area, Ae. albopictus represents
the only Aedes species which is known to bite humans and is the
unique vector of chikungunya. Ae. aegypti, which is non
anthropophilic in Reunion Island is totally absent from the study
area [24]. To check the specificity of this biomarker for Ae.
albopictus, cross-reactivity was tested by comparing IgG Ab levels i)
to Ae. aegypti SGE in individuals from Reunion Island and ii) in sera
from Bolivian subjects who had only ever been exposed to Ae.
aegypti species.
Materials and Methods
Ethics statement
All studies followed ethical principles as stipulated in the
Edinburgh revision of the Helsinki Declaration. The studies in La
Reunion and the North of France were approved by a French
Ethics Committee (the Sud Ouest, Outre Mer Ethics Committee, 25/
02/2009) and authorized by the French Drug Agency (AFFSAPS,
Ministry of Health; 12/01/2009). The study in Bolivia was
approved by the Bolivian Committee of Bioethics (September
2006) and the Institut de Recherche pour le De ´velopement (IRD)
‘‘Comite ´ Consultatif de De ´ontologie et d’Ethique’’ (July 2006). Written
informed consent was obtained from every subject.
Study population
The study populations were from two different areas, namely
Reunion Island and Bolivia, for specific exposure to Ae. albopictus or
Ae. aegypti, respectively.
In the south of Reunion Island (Le Tampon), Ae. albopictus is
abundant and is found up to 1200 meters in winter. Chikungunya
transmission was high during the 2006 epidemic [25]. Blood
samples were collected in May–June 2009 during the seasonal
peak of Ae. albopictus exposure, from adults of between 18 and 30
years of age (n=110). Subjects exposed only to Ae. aegypti were
randomly selected from a large study conducted in the city of
Santa Cruz de la Sierra, Bolivia (n=104) and pair-matched for
age with the Reunion Island subjects. Sera from unexposed
individuals (n=18) in a region free of either Ae. albopictus or Ae.
aegypti (North of France) were used as a negative control.
Collection of Aedes salivary gland extracts
SGE were obtained from 10 day-old uninfected females reared
in insectaries. Ae. albopictus was bred from larvae collected in the
field in Reunion Island (Direction Regionale des Affaires
Sanitaires et Sociales, Saint Denis, Reunion Island) and the
Bora-Bora strain of Ae. aegypti was used (IRD, Montpellier, France).
Briefly, two days after a blood meal, the mosquitoes were sedated
with CO2 and then their salivary glands were dissected out and
transferred into a tube containing 30 ml of phosphate buffered
saline (PBS). The dissected glands were then pooled in 30 or 60
pairs per batch and frozen at 280uC before extraction. A simple
technique consisting of 3 successive freeze-thaw cycles in liquid
nitrogen was used to disrupt the membranes. The soluble SGE
fraction was then separated by centrifugation for 20 minutes at
30,000 g at +4uC. The concentration of protein was evaluated by
the Bradford method (OZ Biosciences) after pooling of the
different batches to generate a homogenous SGE for immunolog-
ical assessment. SGEs were then stored at 280uC before use.
Evaluation of human IgG Ab levels
An enzyme-linked immunosorbent assay (ELISA) was carried
out on Maxisorp plates (Nunc, Roskilde, Denmark) coated with Ae.
albopictus or Ae. aegypti SGE, (0.8 mg/ml PBS) at 37uC for 150 min.
Plates were blocked using 250 ml of protein free Blocking-Buffer
(Pierce, Thermo Fisher, France) for 60 minutes at room
temperature. Individual sera were incubated in duplicate at a 1/
100 dilution in PBS-Tween 1%, 4uC overnight. Monoclonal
mouse biotinylated Ab against human IgG (BD Pharmingen, San
Diego, CA) was incubated at a 1/1000 dilution for 90 minutes at
37uC. Peroxidase-conjugated streptavidin (GE healthcare, Orsay,
France) was added at 1/1000 for 60 minutes at 37uC. Colorimet-
ric development was carried out using ABTS (2,29-azino-bis (3-
ethylbenzthiazoline 6-sulfonic acid) diammonium, Pierce) in
50 mM citrate buffer (pH 4) containing 0.003% H2O2, and
Author Summary
Aedes-borne viruses like dengue and chikungunya are a
major problem in Reunion Island. Assessing exposure to
Aedes bites is crucial to estimating the risk of pathogen
transmission. Currently, the exposure of populations to
Aedes albopictus bites is mainly evaluated by entomolog-
ical methods which are indirect and difficult to apply on a
large scale. Recent findings suggest that evaluation of
human antibody responses against arthropod salivary
proteins could be useful in assessing exposure to
mosquito bites. The results indicate that 88% of the
studied population produce IgG to Ae. albopictus saliva
antigens in Reunion Island and show that this biomarker
can detect different levels of individual exposure. In
addition, little cross-reactivity is observed with Aedes
aegypti saliva, suggesting that this could be a specific
marker for exposure to Aedes albopictus bites. Taken
together, these results suggest that antibody responses to
saliva could constitute a powerful immuno-epidemiolog-
ical tool for evaluating exposure to Aedes albopictus and
therefore the risk of arbovirus infection.
IgG Biomarker for Aedes albopictus Exposure
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assessed in duplicate wells and in a blank well containing no
antigen (ODn) to measure non-specific reactions, as previously
described [17], [23], [26]. Individual results were expressed as the
DOD value calculated using the equation DOD=ODx-ODn,
where ODx represents the mean of the OD readings in the two
antigen wells. A subject was considered as an ‘‘immune
responder’’ if the DOD result was higher than the mean
DOD+(3 SD) for unexposed individuals (negative control). The
threshold of positivity was 0.271 for IgG against Ae. albopictus and
0.161 for IgG against Ae. aegypti.
Statistical analysis
Graph Pad Prism Software (San Diego, CA USA) was used to
analyse the data. After confirmation of non-normal distribution, a
non-parametric Mann-Whitney test was used to compare Ab levels
between two independent groups, and a non-parametric Kruskal-
Wallis test was used for comparisons between more than two
groups. A Spearman test was used to assess the correlation
between IgG levels against Ae. albopictus and Ae. aegypti SGEs. All
differences were considered significant at p,0.05.
Results
IgG response to Ae. albopictus to SGE
IgG responses to Ae. albopictus SGE were evaluated in individuals
from Reunion Island and North of France (Figure 1). In the
unexposed group, one individual IgG response was slightly above
the cut-off value (DOD=0.297) (Figure 1). In contrast, a high
percentage (88%) of the exposed group from La Reunion
responded positively to the anti-SGE IgG Ab. Although
considerable differences in specific Ab level were observed
between exposed individuals (DOD from 0.034 to 3.308), a
significant difference in specific IgG level was observed between
the exposed group (median=1.067) and the unexposed group
(median=0.015) (p,0.0001, Mann-Whitney test).
Evaluation of IgG cross-reactivity with Ae. aegypti SGE
Cross-reactivity between Ae. albopictus and Ae. aegypti SGEs was
evaluated by two complementary approaches. First, the specific
IgG response to both SGEs (Figure 2) was evaluated in individuals
only exposed to Ae. albopictus (from Reunion Island); in parallel,
IgG responses to both SGEs were assessed in individuals only
exposed to Ae. aegypti (from Bolivia). In the Bolivian group, 16%
showed a positive IgG response against Ae. albopictus SGE with only
one strong response (DOD.1). The median (0.107) level of IgG
against Ae. albopictus SGE was significantly lower in the Bolivians
than in the Reunion Island group (1.067) (P,0.0001, Mann-
Whitney test). The IgG response to Ae. aegypti SGE was also
evaluated in both groups of subjects. As expected, the Bolivian
group (exposed only to Ae. aegypti) presented high levels of IgG
against Ae. aegypti SGE with 76% of immune responders. In
contrast, only 19% of the subjects from Reunion Island were
responders to Ae. aegypti SGE and the median (0.068) IgG level was
very low compared with the Bolivian group (0.991) (p,0.0001,
Mann Whitney test). Only one individual from Reunion presented
very high level of IgG to Ae. aegytpi SGE (DOD.3). In addition, in
58% of double immune responders from Reunion Island, the level
of IgG against Ae. albopictus SGE was above the 75% percentile
value (DOD=2.426; data not shown). In the Bolivian double
immune responders, the corresponding figure for Ae. aegypti SGE
was 50% (DOD value of 75% percentile=2.341). These results
Figure 1. Individual IgG response to Ae. albopictus SGE in Reunion Island. Exposed (n=110, Reunion Island) and unexposed individuals
(n=18, North France). Individual IgG Ab responses are represented by DOD. Bars indicate median value in each group and the dotted line represents
the threshold of specific Ab response to Ae. Albopictus SGE (DOD=0.271).
doi:10.1371/journal.pntd.0001487.g001
IgG Biomarker for Aedes albopictus Exposure
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reactive, particularly in individuals presenting a very high level
of IgG.
Secondly, the level of specific IgG Ab against both SGEs was
compared by a statistical correlation analysis (Figure 3). High
positive correlation between IgG against Ae. albopictus SGE and Ae.
aegypti SGE was observed for both the Reunion Island group
(r=+0.445; P,0.0001, Spearman test) and the Bolivian group
(r=+0.617; P,0.0001, Spearman test). For each population, IgG
cross-reactivity was low with few individuals responding to both Ae.
albopictus and Ae. aegypti SGEs. For the Reunion Island group, only
5 individuals showed a strong IgG response to Ae. aegypti SGE.
These correlations indicate that cross-reactivity between the two
Aedes species may depend on IgG level. In the Bolivian group, the
same trend is observed with only 8 individuals showing a strong
IgG response to Ae. albopictus SGE.
Discussion
In this study, we investigated IgG responses to Ae. albopictus SGE
in exposed adults from Reunion Island where Ae. albopictus—the
only anthopophilic Aedes species—transmits chikungunya. First,
specific IgG responses were high in the exposed group and
significantly different to those observed in an unexposed
population from Europe: 88% of exposed individuals developed
IgG against Ae. albopictus SGE. In addition, specific IgG Ab levels
showed considerable inter-individual variations. Since the intensity
of exposure in a given population living in the same area can
obviously vary between individuals, these results suggest that the
anti-SGE IgG response may be a reliable biomarker for exposure
to Ae. albopictus bites. Furthermore, the significant difference in Ab
levels between unexposed and exposed individuals shows that this
biomarker could distinguish individuals exposed to Ae. albopictus
bites. A useful biomarker for Ae. albopictus bites needs to be highly
specific and devoid of immune cross-reactivity with other Aedes
species. We evaluated the cross-reactivity between two species
using complementary approaches, i.e. in individuals only ever
exposed to Ae. aegypti and by analysing IgG levels against both
SGEs. In the Bolivian group only exposed to Ae. aegypti, 16% of
individuals responded to Ae. albopictus SGE (heterologous ELISA).
The DOD values for these ‘‘cross-reactive’’ individuals are
characterised by very low IgG levels whereas a high percentage
(88%) and high IgG levels (homologous ELISA) were observed in
subjects from Reunion Island. In addition, IgG responses against
Ae. aegypti SGE are significantly different: 76% of immune
responders in Bolivia compared with 19% in Reunion Island.
Interestingly, we observed that IgG cross-reactivity was mainly
detected in high immune responders. In Reunion Island, in 58%
of double immune responders, the level of IgG against Ae. albopictus
SGE was above the third quartile. In parallel, in Bolivia, the level
of IgG against Ae. aegypti SGE of 50% of double immune
responders was above the third quartile. Taken together, these
results suggest that there is cross-reactivity between Ae. albopictus
SGE and Ae. aegypti SGE, especially in high immune responders.
Figure 2. Individual IgG response to Ae. albopictus or Ae. aegypti SGE in Reunion Island and Bolivia. Individual IgG responses against Ae.
albopictus SGE and Ae. aegypti SGE are presented in individuals from Reunion Island (black circle) and from Bolivia (white circle). The percentage of
positive responders is indicated for each group. Bars indicate median value in each group. The dotted and solid lines represent the threshold of
specific Ab response to Ae. albopictus (DOD=0.271) and Ae. aegypti SGE (DOD=0.161), respectively.
doi:10.1371/journal.pntd.0001487.g002
IgG Biomarker for Aedes albopictus Exposure
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specific salivary antigens. IgG response to Ae. albopictus SGE has
been detected in individuals exposed to the bites of this mosquito
[27]. It can be hypothesised that, in Reunion Island, the observed
specific IgG responses were elicited as a result of antigenic
stimulation following biting by Ae. albopictus. In the urban area of
Reunion Island, Ae. albopictus is highly antropophilic [28] and
characterised by numerous ‘‘artificial’’ breeding sites [25] which
could explain the high percentage (88%) of specific responders to
Ae. albopictus SGE. These results point up the relevance of this
approach to developing a specific biomarker for exposure to Ae.
albopictus. However epidemiological factors—history of exposure,
genetic background, immune tolerance, etc.—have to be taken
into account when explaining variations in responsiveness. Further
longitudinal studies could focus on this. To our knowledge,
measuring IgGs against Ae. albopictus SGE represents the first direct
method for evaluating human exposure to Ae. albopictus and this
parameter probably represents the first genuine biomarker for
man-vector contact. This method could help overcome the
shortcomings of the current methods which only give indirect
measurements of exposure to Ae. albopictus and therefore have
considerable limitations for evaluating the risk of arbovirus
transmission [7]. The current standard methods—immature stage
counting and trapping techniques—are both ‘‘static’’ and mainly
target ‘‘household exposure’’, ignoring all the anthropogenic
factors that can affect exposure (e.g. water storage practices). Ae.
albopictus and Ae. aegypti are diurnal mosquitoes, biting both indoors
and outdoors, and these characteristics may complicate the
assessment of exposure using conventional methods. Using anti-
SGE IgG responses to evaluate exposure to Ae. albopictus, highly
heterogeneous Ab levels were observed between exposed individ-
uals, as previously reported for another vector [26]. It could be
hypothesized that different levels could reflect the intensity of
exposure to biting vectors, e.g. the experimental results indicate
that a high Ab response is the result of high exposure and the
ame association is also observed for low Ab levels [29]. This has
also been observed in human populations in the field where
arthropods vectors are endemic. In exposed individuals from
endemic areas, it has been shown that the level of anti-saliva
Ab was closely associated with the intensity of exposure to vector
bites [12], [23], [26], [30]. Therefore, this could be a useful tool
for comparing the exposure to Ae. albopictus at different sites in
a given study area or between different areas, and could be useful
for evaluating the efficacy of vector control. In addition, recent
findings in the malaria field have shown that Ab responses to
saliva antigens are useful in the assessment of low-level exposure
to Anopheles bites [31]. Detection of low level exposure in newly
colonized areas is of particular interest for Ae. albopictus due
to its ongoing worldwide spread, especially in urban contexts.
Moreover, a clear correlation between larval indices and
pathogen transmission is difficult to establish when the level of
exposure is low [32], [33]. In both cases, evaluation of the anti-
saliva IgG response could complement entomological methods.
However, several validation steps (e.g. seasonal variation and
correlation with entomological measurements) will have to be
checked.
Figure 3. Individual cross-reactivity IgG response between Ae. albopictus and Ae. aegypti SGE. Correlations between IgG against Ae.
albopictus SGE and Ae. aegypti SGE in Reunion Island (black circle) and Bolivia (white circle). The coefficient of correlation (r) and significance are
indicated for each species SGE, black lines represent linear Spearman correlation.
doi:10.1371/journal.pntd.0001487.g003
IgG Biomarker for Aedes albopictus Exposure
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long as any salivary proteins are shared with other species or
genera, the degree of cross-reactivity with major other Aedes
vectors will have to be assessed. Thus, cross-reactivity was
investigated between Ae. albopictus and Ae. aegypti, closely related
species with shared salivary proteins [34], [35]. Only weak cross-
reactivity was detected between Ae. albopictus and Ae. aegypti SGEs,
mainly observed in high immune responders. This may suggest
that species-specific proteins are more immunogenic than genus-
shared proteins. Species-specificity has been already reported with
several Aedes species [20], [23], [36] and for a broad range of
vectors [12], [29], [37]. In contrast, western-blot analysis reveals
extensive cross-reactivity and shows that some antigens are
common to all Aedes species [21], [38], [39]. This low level of
cross-reactivity also raises the roles of intensity and history of
exposure in determining the acquired IgG response against SGE.
Individuals from Reunion Island are unlikely to have been
exposed to Ae. aegypti because this mosquito is not found in town
and its breeding sites are restricted to natural habitats [24]. Cross-
reactivity between salivary proteins common to all members of the
Aedes genus seems therefore to be the most likely explanation of the
observed IgG responsiveness to Ae. aegypti SGE in Reunion Island.
Travelling could also lead to contact with Ae. aegypti which is
present in most of the islands of the Indian Ocean.
To enhance the usefulness of this biomarker for large-scale
applications and to exclude cross-reactivity, an Ae. albopictus-
specific salivary antigen needs to be identified. In malaria, only
one peptide in whole Anopheles salivary antigen is an efficient
biomarker for exposure to Anopheles bites [30]. To improve the
sensitivity and the specificity of detection, an immuno-proteomic
study is currently underway to identify Ae. albopictus-specific
proteins and peptides.
The study described here represents the first step for estimating
human exposure to Ae. albopictus by quantifying the IgG response
to vector salivary antigens. In an area of chikungunya transmis-
sion, it was shown that the level of Ab against Ae. albopictus SGE
can be used to identify individuals who have been exposed to the
bites of this important vector. Low level cross-reactivity was
observed with Ae. aegypti SGE suggesting that it will be possible to
develop a specific biomarker for human exposure to biting Ae.
albopictus. By combining the use of such a biomarker with classical
entomological and epidemiological methods, it could enhance the
assessment of human exposure to Ae. albopictus and therefore
contribute to both accurate prediction of the risk of arbovirus
transmission and evaluation of the efficacy of vector control.
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